Lingxin Meng

2.0k total citations
27 papers, 542 citations indexed

About

Lingxin Meng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lingxin Meng has authored 27 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Lingxin Meng's work include Peptidase Inhibition and Analysis (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Cardiac Structural Anomalies and Repair (4 papers). Lingxin Meng is often cited by papers focused on Peptidase Inhibition and Analysis (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Cardiac Structural Anomalies and Repair (4 papers). Lingxin Meng collaborates with scholars based in China, Singapore and Denmark. Lingxin Meng's co-authors include Jianyang Fang, Zhide Guo, Jiahui Ren, Zhe Wang, Pengyun Zhao, Zhenguo Zhang, Jingmei Xu, Haojun Chen, Bingcheng Li and Liang Zhao and has published in prestigious journals such as Journal of Controlled Release, Journal of Medicinal Chemistry and Journal of Membrane Science.

In The Last Decade

Lingxin Meng

27 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingxin Meng China 12 182 171 109 95 83 27 542
Mengjia Zhao China 13 62 0.3× 216 1.3× 121 1.1× 121 1.3× 86 1.0× 33 853
Shino Nakagawa Japan 13 125 0.7× 107 0.6× 72 0.7× 39 0.4× 100 1.2× 27 534
Monireh Golpour Iran 17 60 0.3× 312 1.8× 152 1.4× 29 0.3× 87 1.0× 50 744
Muzhou Teng China 14 110 0.6× 196 1.1× 66 0.6× 58 0.6× 141 1.7× 32 527
Nitin B. Charbe United States 13 58 0.3× 282 1.6× 100 0.9× 81 0.9× 201 2.4× 33 661
Li Xu China 13 115 0.6× 168 1.0× 66 0.6× 71 0.7× 42 0.5× 84 607
Hajar Yaghoobi Iran 12 58 0.3× 264 1.5× 82 0.8× 50 0.5× 149 1.8× 35 669
Fangqin Xue China 15 78 0.4× 370 2.2× 110 1.0× 80 0.8× 286 3.4× 39 724
Yixin He China 17 38 0.2× 312 1.8× 68 0.6× 33 0.3× 207 2.5× 21 676
Aili Zhang China 13 102 0.6× 229 1.3× 37 0.3× 31 0.3× 188 2.3× 35 660

Countries citing papers authored by Lingxin Meng

Since Specialization
Citations

This map shows the geographic impact of Lingxin Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingxin Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingxin Meng more than expected).

Fields of papers citing papers by Lingxin Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingxin Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingxin Meng. The network helps show where Lingxin Meng may publish in the future.

Co-authorship network of co-authors of Lingxin Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Lingxin Meng. A scholar is included among the top collaborators of Lingxin Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingxin Meng. Lingxin Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Lingxin, Jianyang Fang, Rongqiang Zhuang, et al.. (2025). Development of radioligands with an albumin-binding moiety of 4-(P-Iodophenyl) butyric acid for theranostic applications. Journal of Controlled Release. 382. 113757–113757. 3 indexed citations
2.
Li, Huifeng, Dongsheng Xia, Lingxin Meng, et al.. (2025). FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics. Journal of Controlled Release. 382. 113678–113678. 9 indexed citations
3.
Meng, Lingxin, Jianyang Fang, Jingru Zhang, et al.. (2024). Rational Design and Comparison of Novel 99mTc-Labeled FAPI Dimers for Visualization of Multiple Tumor Types. Journal of Medicinal Chemistry. 67(10). 8460–8472. 11 indexed citations
4.
Fang, Jianyang, Xiaobo Wang, Lingxin Meng, et al.. (2024). Preclinical Evaluation of 131I/18F-Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging. ACS Pharmacology & Translational Science. 7(6). 1783–1794. 3 indexed citations
5.
Xue, Tongtong, Qianyi Zhang, Tiantian Zhang, et al.. (2024). Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice. BMC Pulmonary Medicine. 24(1). 456–456. 4 indexed citations
6.
Fang, Jianyang, Jingru Zhang, Lingxin Meng, et al.. (2024). 18F-Labeled Amidobenzimidazole Analogue for Visualizing STING Expression in Tumor. Molecular Pharmaceutics. 21(4). 1942–1951. 2 indexed citations
7.
Li, Wenqi, Jing Liu, Zhigang Liu, et al.. (2024). Baricitinib alleviates cardiac fibrosis and inflammation induced by chronic sympathetic activation. International Immunopharmacology. 140. 112894–112894. 4 indexed citations
8.
Li, Wenqi, Jing Liu, Zhigang Liu, et al.. (2023). Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation. Molecules. 28(16). 6035–6035. 6 indexed citations
9.
Wen, Xuejun, Peng‐Fei Xu, Xinying Zeng, et al.. (2023). Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression. European Journal of Nuclear Medicine and Molecular Imaging. 50(9). 2846–2860. 27 indexed citations
10.
Pang, Yizhen, Liang Zhao, Jianyang Fang, et al.. (2023). Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy. Journal of Nuclear Medicine. 64(9). 1449–1455. 56 indexed citations
11.
Meng, Lingxin, Jianyang Fang, Liang Zhao, et al.. (2022). Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein. Journal of Medicinal Chemistry. 65(12). 8245–8257. 46 indexed citations
12.
Liu, Huanhuan, Duo Xu, Jingchao Li, et al.. (2022). Radioiodinated Ethinylestradiol Derivatives for Estrogen Receptor Targeting Breast Cancer Imaging. ACS Medicinal Chemistry Letters. 13(2). 203–210. 3 indexed citations
13.
Fang, Jianyang, Lingxin Meng, Xiaobo Wang, et al.. (2022). A novel 18F-labeled agonist for PET imaging of stimulator of interferon gene expression in tumor-bearing mice. European Journal of Nuclear Medicine and Molecular Imaging. 50(1). 27–37. 12 indexed citations
14.
Zhang, Jing, Lingxin Meng, Yu Peng, ­Jun Li­, & Jiadong Yu. (2021). MiR-155 promotes the migration and invasion of esophageal squamous cell carcinoma via downregulating PTEN. Minerva Medica. 112(1). 155–157. 1 indexed citations
15.
Liu, Xingjun, Yunsong Lian, Zhenhang Chen, et al.. (2020). Macrophage Depletion Improves Chronic Rejection in Rats With Allograft Heart Transplantation. Transplantation Proceedings. 52(3). 992–1000. 7 indexed citations
16.
Chen, Ming, Jian Liu, Weitao Chen, et al.. (2019). Prevention and treatment of infectious diseases by traditional Chinese medicine: a commentary. Apmis. 127(5). 372–384. 65 indexed citations
17.
Meng, Lingxin, Qiang Ren, Qin Meng, et al.. (2018). Trastuzumab modified silica nanoparticles loaded with doxorubicin for targeted and synergic therapy of breast cancer. Artificial Cells Nanomedicine and Biotechnology. 46(sup3). 556–563. 25 indexed citations
18.
Meng, Lingxin, Fengsong Wang, Zhaojun Ding, et al.. (2017). MicroRNA-30b targets CBX3 and regulates cell proliferation, apoptosis, and migration in esophageal squamous cell carcinoma via the JAK2/STAT3 signaling pathway.. PubMed. 10(12). 11828–11837. 8 indexed citations
19.
Wang, Mingfang, et al.. (2017). Recent advances in mechanism-based chemotherapy drug-siRNA pairs in co-delivery systems for cancer: A review. Colloids and Surfaces B Biointerfaces. 157. 297–308. 40 indexed citations
20.
Qin, Bin, Yuxin Li, Lingxin Meng, et al.. (2015). “Mirror-Image” Manipulation of Curdione Stereoisomer Scaffolds by Chemical and Biological Approaches: Development of a Sesquiterpenoid Library. Journal of Natural Products. 78(2). 272–278. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengjia Zhao Breakdown of academic impact, for papers by Shino Nakagawa Breakdown of academic impact, for papers by Monireh Golpour Breakdown of academic impact, for papers by Muzhou Teng Breakdown of academic impact, for papers by Nitin B. Charbe Breakdown of academic impact, for papers by Li Xu Breakdown of academic impact, for papers by Hajar Yaghoobi Breakdown of academic impact, for papers by Fangqin Xue Breakdown of academic impact, for papers by Yixin He Breakdown of academic impact, for papers by Aili Zhang
Rankless by CCL
2026